At a glance
ClinicalIndex Comparison RecordN/ACompleted
Drug / intervention
fluoxetine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Fluoxetine as a Quit Smoking AID for Depression Prone
National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Jun 10, 2005·Updated Feb 18, 2016
In Brief
A clinical study evaluating fluoxetine and cognitive behavioral therapy for Cardiovascular Diseases and Heart Diseases. Completed.
Detailed Summary
To test whether adding fluoxetine pharmacotherapy to behavioral cessation treatment improves the depression-prone smoker's ability to quit.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Heart Diseases
Countries--
Collaborators--
Timeline
N/ACompletedFinished
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 1998
Study CompletionJan 2002
First PostedJun 2005
TodayJul 2026
First PostedJun 10, 2005
Enrollment StartFeb 1, 1998
Study CompletionJan 1, 2002
TodayJul 2, 2026
Posted 21.1 years ago
Interventions
fluoxetinedrug
cognitive behavioral therapybehavioral